Under an agreement announced Monday, Feb. 23, Organon will pay $27.5 million upfront for the right to market Sebela’s Miudella, billed as the first FDA-approved device of its kind in 40 years.
The research in this week’s report investigates new energy storage materials and processes and advanced nuclear and fusion power ...
One of the symptoms of Wilson's disease (hepatolenticular degeneration) is an increased output of copper in the urine. This now seems to be linked with a defect in the binding of copper to amino-acid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results